These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 22185740
21. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS. Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225 [Abstract] [Full Text] [Related]
22. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years. Lue KH, Sun HL, Lu KH, Ku MS, Sheu JN, Chan CH, Wang YH. Int J Pediatr Otorhinolaryngol; 2012 Jul; 76(7):994-1001. PubMed ID: 22513081 [Abstract] [Full Text] [Related]
23. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P. Am J Rhinol Allergy; 2011 Jul; 25(1):e1-6. PubMed ID: 21711959 [Abstract] [Full Text] [Related]
24. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO. Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145 [Abstract] [Full Text] [Related]
25. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G, XPERT Study Group. J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324 [Abstract] [Full Text] [Related]
26. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis. Ciprandi G, Tosca MA, Milanese M, Ricca V. Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007 [Abstract] [Full Text] [Related]
27. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. Ciprandi G, Cirillo IG, Vizzaccaro A, Tosca MA. Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374 [Abstract] [Full Text] [Related]
28. Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial. Khan MA, Abou-Halawa AS, Al-Robaee AA, Alzolibani AA, Al-Shobaili HA. J Laryngol Otol; 2010 Apr; 124(4):397-401. PubMed ID: 19930776 [Abstract] [Full Text] [Related]
29. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Meltzer EO. Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557 [Abstract] [Full Text] [Related]
30. Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry. Orgel HA, Meltzer EO, Kemp JP, Ostrom NK, Welch MJ. Ann Allergy; 1991 Mar; 66(3):237-44. PubMed ID: 1672493 [Abstract] [Full Text] [Related]
31. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis. Sastre J, Mullol J, Valero A, Valiente R, Bilastine Study Group. Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106 [Abstract] [Full Text] [Related]
32. Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults. Given JT, Cheema AS, Dreykluft T, Stillerman A, Silvey M, Wu W, Snowise NG, Philpot E. Am J Rhinol Allergy; 2010 Jan; 24(6):444-50. PubMed ID: 21144223 [Abstract] [Full Text] [Related]
33. Nasal nitric oxide is increased in allergic rhinitis. Arnal JF, Didier A, Rami J, M'Rini C, Charlet JP, Serrano E, Besombes JP. Clin Exp Allergy; 1997 Apr; 27(4):358-62. PubMed ID: 9146927 [Abstract] [Full Text] [Related]
34. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. Segall N, Gawchik S, Georges G, Haeusler JM. Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116 [Abstract] [Full Text] [Related]
35. Effect of nebulized beclomethasone on airway inflammation and clinical status of children with allergic asthma and rhinitis: a randomized, double-blind, placebo-controlled study. Profita M, Riccobono L, Bonanno A, Chanez P, Gagliardo R, Montalbano AM, Albano GD, Liotta G, Gjomarkaj M, La Grutta S. Int Arch Allergy Immunol; 2013 Mar; 161(1):53-64. PubMed ID: 23257680 [Abstract] [Full Text] [Related]
36. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. de Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959 [Abstract] [Full Text] [Related]
37. A 26-week tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis. Berger WE, Mohar DE, LaForce C, Raphael G, Desai SY, Huang H, Hinkle J. Am J Rhinol Allergy; 2012 May; 26(4):302-7. PubMed ID: 22801019 [Abstract] [Full Text] [Related]
38. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Meltzer EO, Munafo DA, Chung W, Gopalan G, Varghese ST. Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206 [Abstract] [Full Text] [Related]
39. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, Philpot E. Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084 [Abstract] [Full Text] [Related]